GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug ...
The US group's division has reported a pre-tax profit of $39.5m (£30.6m) for the 12 months to 31 January, 2024, according to ...
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback